Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. Choosing the wrong investments can cause you to fall behind, which is why we started StockStory - to separate the winners from the losers. Keeping that in mind, here is one low-volatility stock that could offer consistent gains and two that may not deliver the returns you need. Two Stocks to Sell: CONMED (CNMD) Rolling One-Year Beta: 0.17 With over five decades of experience in surgical innovation since its founding in 1970, CONMED (NYSE:CNMD) develops and manufactures medical devices and equipment for surgical procedures, specializing in orthopedic and general surgery products. Why Does CNMD Give Us Pause? Muted 6.7% annual revenue growth over the last five years shows its demand lagged behind its healthcare peers Modest revenue base of $1.32 billion gives it less fixed cost leverage and fewer distribution channels than larger companies Low returns on capital reflect management’s struggle to allocate funds effectively CONMED’s stock price of $57.68 implies a valuation ratio of 12.9x forward P/E. Check out our free in-depth research report to learn more about why CNMD doesn’t pass our bar. Agilent (A) Rolling One-Year Beta: 0.85 Originally spun off from Hewlett-Packard in 1999 as its measurement and analytical division, Agilent Technologies (NYSE:A) provides analytical instruments, software, services, and consumables for laboratory workflows in life sciences, diagnostics, and applied chemical markets. Why Do We Think Twice About A? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth Anticipated sales growth of 4.1% for the next year implies demand will be shaky Adjusted operating margin declined by 1.1 percentage points over the last two years as its sales cratered At $108.63 per share, Agilent trades at 19x forward P/E. If you’re considering A for your portfolio, see our FREE research report to learn more. One Stock to Watch: Parsons (PSN) Rolling One-Year Beta: 0.55 Delivering aerospace technology during the Cold War-era, Parsons (NYSE:PSN) offers engineering, construction, and cybersecurity solutions for the infrastructure and defense sectors. Why Could PSN Be a Winner? Annual revenue growth of 23.8% over the past two years was outstanding, reflecting market share gains this cycle Operating profits and efficiency rose over the last five years as it benefited from some fixed cost leverage Share buybacks catapulted its annual earnings per share growth to 35%, which outperformed its revenue gains over the last two years Story Continues Parsons is trading at $62.67 per share, or 16.7x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free. Stocks That Overcame Trump’s 2018 Tariffs The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like United Rentals (+322% five-year return). Find your next big winner with StockStory today for free. View Comments
1 Safe-and-Steady Stock to Consider Right Now and 2 to Be Wary Of
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...